Will Johnson & Johnson say “Darzalex Faspro”?
Johnson & Johnson said “Darzalex Faspro” 1 time on its Oct 13, 2026 call (FY26 Q3), and on 3 of its last 8 calls: 0, 0, 0, 0, 0, 2, 1, 1 times. As of Oct 24, 2026, Johnson & Johnson said “Darzalex Faspro” on 3 of 4 calls with a settled Kalshi or Polymarket mention market since Jan 21, 2026 (75%), most recently on Oct 13, 2026. Parrot’s p for the next listing is 63% (n=4, from settlement history blended with transcripts), not a forecast.
- Last 10
- 3/4Last 10 settled, oldest to newest: no yes yes yes
- Streak
- said the last 3 times
- Counts
- company speakers + operator
- Market
- 69¢ Kalshi (may be delayed)
Where it was said
quotes of at most 25 words; select an appearance
Johnson & Johnson
Darzalex Faspro
- Probability
- 63% · n=4
- Settled
- 3/4 (75%)
- Last calls
- said in 3 of 8
Next listing counts: company speakers + operator
Counts: company speakers + operator
1 counted (1 in prepared remarks, 0 in Q&A).
…of therapy following last quarter's approval in the U.S. for TECVAYLI plus DARZALEX FASPRO, with U.S. growth greater than 100%. TALVEY growth was 42.1%, driven…
Counts: company speakers + operator
1 counted (1 in prepared remarks, 0 in Q&A).
…of therapy following last quarter's approval in the U.S. for TECVAYLI plus DARZALEX FASPRO and from expansion in the community setting. TALVEY growth was 62.6%,…
Counts: company speakers + operator
2 counted (2 in prepared remarks, 0 in Q&A).
…our pipeline accelerated in Q1 with the FDA approval of TECVAYLI plus DARZALEX FASPRO for relapsed or refractory multiple myeloma. That positions the regimen as…
…the community setting, as well as the U.S. approval of TECVAYLI plus DARZALEX FASPRO. TALVEY growth was 72.8%, driven by share gains through expansion in…
Every settled listing
newest first · 5 shown| Date | Listed as | Venue | Result | Our count |
|---|---|---|---|---|
| Oct 13, 2026 | Darzalex Faspro |  Kalshi | Yes | 1 |
| Jul 15, 2026 | Darzalex Faspro | Kalshi | Yes | 1 |
| Apr 14, 2026 | Darzalex Faspro | Kalshi | Yes | 2 |
| Jan 21, 2026 | Darzalex Faspro |  Polymarket | No | 0 |
| Jan 21, 2026 | Darzalex Faspro | Kalshi | No | 0 |
Questions
- How many times did Johnson & Johnson say “Darzalex Faspro” on its last earnings call?
- Johnson & Johnson said “Darzalex Faspro” 1 time on its Oct 13, 2026 call (FY26 Q3), and on 3 of its last 8 calls: 0, 0, 0, 0, 0, 2, 1, 1 times.
- How often does Johnson & Johnson say “Darzalex Faspro”?
- As of Oct 24, 2026, Johnson & Johnson said “Darzalex Faspro” on 3 of 4 calls with a settled Kalshi or Polymarket mention market since Jan 21, 2026 (75%), most recently on Oct 13, 2026.
- What is the probability Johnson & Johnson says “Darzalex Faspro” next time?
- 63%, from settlement history blended with transcripts (n=4). It is a base rate from history, not a forecast and not advice.
- Who has to say it for the market to count?
- Under the next market's rule: company speakers + operator.
Cite parrot.markets, “Johnson & Johnson: ‘Darzalex Faspro’ mention history”, as of Oct 24, 2026, https://parrot.markets/earnings/JNJ/words/darzalex-faspro (CC BY 4.0)
Agents: this page as TSV at /api/v1/word?entity=johnson-and-johnson&word=darzalex%20faspro · quotes: /api/v1/quotes?entity=johnson-and-johnson&word=… · columnar JSON in #parrot-data · llms.txt · MCP